Conroe ADHD Solutions

Size: px
Start display at page:

Download "Conroe ADHD Solutions"

Transcription

1 Diagnosis and Medical Management of ADD/ADHD How do we make the diagnosis of ADD/ADHD? We are very careful to be sure we have the diagnosis correct before considering treatment. In the past there were only parent and teacher assessment surveys available. But now we have a more objective method in the computerized McLean Motion and Attention Test developed at Harvard University. Commercially known as the Quotient Test, it is the only objective test of ADD/ADHD approved by the FDA. Combining the Vanderbilt Assessments (the American Academy of Pediatrics standard) and the Quotient Test we can be very certain we are not over-diagnosing this disorder. In addition, we have quantitative parameters that we can refer to later to measure the response to treatment. What is the typical Evaluation Schedule? Visit I - Initial History and Physical (45 minutes) Information is obtained about the child's symptoms and past medical problems that may be related to AD/HD, school performance, and behavior problems. A physical exam is done to determine the physical state of the child and if any neurological or developmental abnormalities arc present. Recent hearing and vision screens are requested from the PCP. The Vanderbilt Assessment for Teacher and Parents is given to the parent. The Teacher version is accompanied by a letter and instructions to the teacher(s) to fill it out and return it by mail or Fax. We do not want the evaluation shared with the child or the parent before the next meeting. For third grade and above, two teachers are selected in major subjects - one in humanities and the other in math or science. The Parent version is filled out by both parents if possible and brought in at the next visit. This second visit is scheduled for 3-5 days after the teachers have mailed their evaluations so we are certain to have all the evaluations available for scoring and review. In addition, the parent will be asked to schedule the McClean Motion and Attention Assessment (Quotient test) at the office of Lake Area Pediatrics (phone (936) in Montgomery. This test is only given on Tuesday, Wednesday and Thursday mornings. Your insurance will almost always reimburse for this test. This is a computer test that measures motion and attention to figures on the computer screen. The test for children age 6 through 12 lasts for 15 minutes while the adolescent test lasts twenty minutes. This is the first FDA-approved system for the objective measurement of hyperactivity, impulsivity and inattention as an aid in the assessment of ADHD. Finally parents are encouraged to get onto the web-site ( and read about the medications and other resource materials November 6,

2 Visit 2- Quotient ADHD test (30 min) The Quotient ADHD test is given on Tuesday, Wednesday and Thursday mornings. Patients being evaluated for ADHD for the first time are required to take this test for diagnosis and for those already on medication to establish performance. Information on the Quotient test is on the website. Visit 3- Review of Quotient and Vanderbilt Assessments (30-45 min) Quotient and Parent and Teacher Vanderbilts are reviewed and it is determined if the child has enough factors to establish the diagnosis of AD/HD. If the diagnosis is confirmed we discuss the options for treatment including medications. A prescription may be dispensed at this time. All stimulants are Schedule II drugs and require a special license for dispensing and special rules for filling and re-filling. Usually the insurance companies will not allow more than 30 days at a time to be filled. A medication schedule is devised at this visit and a review of side effects. A chart is given to the parent to record side effects. The medications are almost always started on a Saturday at the lowest dose in order for the parent to be able to monitor side effects. The dose is increased at weekly intervals as needed to get the desired effect. Frequent visits are often needed to establish the correct dose for each child. Visit 4- First follow-up visit on medication (30 min) This visit usually occurs days after starting the medications to monitor for adverse side effects, check blood pressure and heart rate and determine how well the adjusted dose is addressing the patient's problems. As long as the dose is being increased the patient is seen every two weeks. Once we are satisfied that a particular dose is effective the child will be monitored on that dose. Subsequent visits - Adjusting the dose These visits will be at least monthly or more frequent if the dose must be altered more often tor tuning or to decrease side effects. Once the dose is established with the desired result for at least two months these visits are stretched out. Subsequent visits - Maintaining the dose If the dose is not changed for two months and we are satisfied with the result, the child visits are only necessary every 3-6 months. After the child has been on a fixed dose of medication for 6 months, they will progress to semi-annual visits -- only be required every about every 6 months-- in the Fall (September or October) and again in the Spring (February or March). November 6,

3 How do we treat the patient with the diagnosis of ADD/ADHD? Most of the medications used to treat ADD/ADHD are stimulants and derivatives of methylphenidate (Ritalin-like) or dextroamphetamine (Adderall-like). There has been more than half a century of experience in the use of these preparations. We know their benefits and there side effects well. Some people are more sensitive than others. There is no simple weight-based dose. We have some adolescents on tiny doses with good effect and some kindergartners that need to be increased to very high doses to get the same beneficial effects. It depends on their genetics and how the liver metabolizes the drugs. The side effects of these medications are discussed below. In the past several years a few non-stimulant medications have come out like Strattera, Intuniv, and Kapvay. In most cases, these medications have not proven as effective as the stimulants. They are used in special cases where the stimulants are not beneficial or when not tolerated well or to supplement. Once the diagnosis has been established, the parent must decide if they wish to treat the ADD/ADHD. The treatment is the same for either or both conditions. Most children will have only ADD, but many have a combined ADD with hyperactivity (ADHD). Very few have ADHD alone. Medications usually prescribed include: Ritalin derivatives: Focalin XR Concerta Ritalin Capsule (sprinkled) Tablet Tablet Adderall derivatives: Vyvanse Adderall XR Capsule (may be dissolved in water or chewable) Capsule (sprinkled) Check with your insurance company to see what they cover and what you need to pay. These medications can be expensive and are used for months out of the year. How do we determine the dose and manage the patient? We start a patient on the lowest dose possible of any of the stimulant meds in order to avoid any side effects. And these meds are always started on a weekend morning when the parent is available to assess their child s response. If there are no adverse side effects noted by the parent by Sunday evening, it is recommended that they may take the medication on Monday before going to school. We try to start meds that are long-acting to avoid having to give a dose in the middle of the day. This avoids disrupting the child s November 6,

4 school schedule and the stigma of having to take medications at school. Often we see no response to the medication at the very low doses in the first 1-2 weeks. But that is more desirable than having an adverse effect. We usually increase the dose no quicker than one step per week. For instance, for Focalin XR we would start at 5 mg the first week and if no adverse effects and no significant improvement in symptoms after a week, we would increase to 5 mg x 2 (10 mg). This is called titration. This would go on until we are getting the result we wish to see (usually only 2-3 weeks). The result sought is a decrease in ADD/ADHD symptoms like decreased excitability, impulsivity, fidgeting, disturbing others and an increase in attentiveness evidenced by improved handwriting, the ability to finish assignments in class and at home, and improved grades. Dr. Robinson will develop a medical management calendar with the parent or guardian with clear indication of dose and date to be given. The most important part of this calendar is the part that indicates when the parent should contact the doctor to report on his/her progress. These dates will be clearly indicated. It is usually Tuesday and Friday each week by phone or Portal message. The Friday contact is important to discuss whether we should increase the dose to the next level the following day (Saturday AM). The next office visit will usually be required two weeks after starting medications. Once this calendar is reviewed, the parent will be asked to sign a contract agreeing that they understand the dosage regimen and the requirement to report according to the schedule. If the parent fails to contact the doctor as agreed, the titration will be delayed or the patient may be discontinued from the protocol. At no time should a parent take it on themselves to increase the dose without the doctor s consent. The parent can stop it at any time. These medications are Controlled Substances and highly regulated. More discussion in this regard to follow. What are the typical side effects of stimulants? Since these medications are stimulants, they can cause the same side effect as any stimulant like caffeine, tea, Coca-cola, or the popular energy drinks. In order of decreasing frequency they may include: 1) Appetite loss Usually at lunch time when the blood level is highest. This can be minimized by drinking a protein shake at lunch like Boost or Ensure. 2) Stomachache Usually just after taking the medication in the morning at the onset of therapy. It is recommended to always take these meds with food and best with a high-protein meal (like eggs, meat, cheese, yogurt, or Instant Breakfast). 3) Trouble sleeping which is often part of the ADHD (not the medication effect) 4) Anxiety, increased worry, emotional lability (cries more easily) 5) Headache 6) Picking at fingers, nail biting, or lip chewing If an adverse side effect is noted that is concerning, the parent should not administer the next day s dose. In most cases, these medications are rapidly cleared from the body by the same afternoon. If concerned, call the office number on the weekend or November 6,

5 Dr. Robinson on Monday morning (he is the on-call doctor most weekends). On the other side of that, the beneficial effects of the medication can be noted within hours if the dose is correct for that child. How do we get the medications refilled? As mentioned above, these medications are controlled substances (Schedule II) just like codeine, cocaine, oxycodone, morphine and methadone. We must follow a very rigid set of regulations in order to have the license to prescribe them. The reason they are Schedule II is because of the potential for abuse by persons seeking a high. ADD/ADHD patients do not react that way. The prescriptions can be written on a special form that is supplied by the Texas State Board of Pharmacy and each one is traced monthly. However, Dr. Robinson has the ability to write all his prescriptions electronically even the controlled substances from my office medical software. The script goes directly to the pharmacy for pick-up the same day. No pick-up at the office is necessary. The Rx must be obtained from the pharmacy within 21 days of transmission. When a refill is needed the parent must send Dr. Robinson a request message (via the Portal) and that request is documented in the chart. Refills are usually processed in the evening or sooner during the week. Dr. Robinson will send a portal message confirming that the Rx is ready to pick up at the pharmacy. This works much better than phoning in a request and is the reason we prefer all these patients be on the Portal. Do not wait until there are only two pills left to request a refill! I attest that I have read this information, understand it and agree to comply by the conditions outlined above. Signed Date Printed Name November 6,

Parents Guide to ADHD Medications. Copyright Child Mind Institute

Parents Guide to ADHD Medications. Copyright Child Mind Institute Copyright 2017. Child Mind Institute Children with attention-deficit hyperactivity disorder (ADHD) find it unusually difficult to concentrate on tasks, to pay attention, to sit still and to control impulsive

More information

Attention Deficit Hyperactivity Disorder (ADHD) in Children under Age 6

Attention Deficit Hyperactivity Disorder (ADHD) in Children under Age 6 in Children under Age 6 Level 0 Conduct comprehensive assessment and provide psychoeducation about ADHD, including clearly defined treatment expectations. Consider co-morbid developmental language disorder,

More information

Pharmacologic Management of ADHD

Pharmacologic Management of ADHD Pharmacologic Management of ADHD CHADD Presentation April 13, 2015 Peter J Chung, MD, FAAP Developmental-Behavioral Pediatrician* Assistant Clinical Professor of Pediatrics University of California Irvine

More information

ADHD Packet FOLLOW UP Medical Drive, Suite 310 l San Antonio, Texas l Tel: l Fax:

ADHD Packet FOLLOW UP Medical Drive, Suite 310 l San Antonio, Texas l Tel: l Fax: ADHD Packet FOLLOW UP 5282 Medical Drive, Suite 310 l San Antonio, Texas 78229 l Tel: 210-614-8687 l Fax: 210-614-7529 D5 NICHQ Vanderbilt Assessment Follow-up PARENT Informant Today s Date: Child s Name:

More information

NICHQ Vanderbilt Assessment Follow-up PARENT Informant

NICHQ Vanderbilt Assessment Follow-up PARENT Informant D5 NICHQ Vanderbilt Assessment Follow-up PARENT Informant Today s Date: Child s Name: Date of Birth: Parent s Name: Parent s Phone Number: Directions: Each rating should be considered in the context of

More information

Follow Up ADHD Monitoring

Follow Up ADHD Monitoring Follow Up ADHD Monitoring Child's name'----------- Age Age at diagnosis Date today Parent e-mail Phone. School Grade Teacher Most recent report card grades: Math EngUsh R... ea.,..m......,n'f!ig...history

More information

NICHQ Vanderbilt Assessment Follow-up PARENT Informant

NICHQ Vanderbilt Assessment Follow-up PARENT Informant D5 NICHQ Vanderbilt Assessment Follow-up PARENT Informant Today s Date: Child s Name: Date of Birth: Parent s Name: Parent s Phone Number: Directions: Each rating should be considered in the context of

More information

AD/HD is a mental disorder, and it often lasts from

AD/HD is a mental disorder, and it often lasts from short version10 WHAT WE KNOW Managing Medication for Adults with AD/HD AD/HD is a mental disorder, and it often lasts from childhood into adulthood. Medication is the basic part of treatment for adults.

More information

Dose Range. Dose Schedule. Child: 5-60 mg Over 50 kg:5-100 mg Focalin, child: mg Over 50 kg: mg. Focalin: 4-5 hrs.

Dose Range. Dose Schedule. Child: 5-60 mg Over 50 kg:5-100 mg Focalin, child: mg Over 50 kg: mg. Focalin: 4-5 hrs. MEDICATIONS FOR ADHD Group Main Use Medication Brand/ Form Dose Schedule Dose Range Most Common Side Effects for Group Pros for Group Cautions for Group methylphenidate Methylin Focalin (dexmethylphenidate)

More information

ADHD Medications: Basics. David Benhayon MD, PhD

ADHD Medications: Basics. David Benhayon MD, PhD ADHD Medications: Basics David Benhayon MD, PhD Goals & Objectives Understand basic classes of stimulants and equivalents Be exposed to role of nonstimulant alternatives Discuss the role of therapy in

More information

Attention Deficit Hyperactivity Disorder or ADHD

Attention Deficit Hyperactivity Disorder or ADHD Diagnosis/Disease/Illness Si usted desea esta información en español, por favor pídasela a su enfermero o doctor. Name of Child: Date: Attention Deficit Hyperactivity Disorder or ADHD What it is: Children

More information

THE FACTS ABOUT PRESCRIPTION MEDICINE MISUSE

THE FACTS ABOUT PRESCRIPTION MEDICINE MISUSE JUNE This month, Health is Primary is focusing on safe use of prescription medicines. We are sharing the facts about the risks of medicine misuse and the importance of using medicines as prescribed along

More information

Attention Deficit (Hyperactivity) Disorder What you need to know in 12 pages!

Attention Deficit (Hyperactivity) Disorder What you need to know in 12 pages! Attention Deficit (Hyperactivity) Disorder What you need to know in 12 pages! Available as an ebook at www.tonymander.com.au CONSULTANT PSYCHIATRIST Suite 62, Hollywood Medical Centre, 85 Monash Ave, Nedlands,

More information

ADHD FOLLOW-UP VISITS FOR STUDENTS IN MIDDLE SCHOOL OR HIGH SCHOOL

ADHD FOLLOW-UP VISITS FOR STUDENTS IN MIDDLE SCHOOL OR HIGH SCHOOL BROOKLYN PARK OFFICE (763) 425-1211 FAX (612) 874-2907 CALHOUN OFFICE (952) 562-8787 FAX (612) 874-2909 MAPLE GROVE OFFICE Bass Lake Center (763) 559-2861 FAX (612) 874-2902 PLYMOUTH OFFICE WestHealth

More information

GA KS KY LA MD NJ NV NY TN TX WA Applicable X N/A N/A X N/A X X X X X X N/A N/A X *FHK- Florida Healthy Kids. ADHD Narcolepsy

GA KS KY LA MD NJ NV NY TN TX WA Applicable X N/A N/A X N/A X X X X X X N/A N/A X *FHK- Florida Healthy Kids. ADHD Narcolepsy Override(s) Prior Authorization ADHD Narcolepsy Approval Duration 1 year *Louisiana, Washington and Maryland Medicaid See State Specific Information Below Medications Atomoxetine: Strattera generic Clonidine

More information

PHARMACY COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 3/15/18 SECTION: DRUGS LAST REVIEW DATE: 3/15/18 LAST CRITERIA REVISION DATE: ARCHIVE DATE:

PHARMACY COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 3/15/18 SECTION: DRUGS LAST REVIEW DATE: 3/15/18 LAST CRITERIA REVISION DATE: ARCHIVE DATE: DYANAVEL XR (amphetamine) extended-release oral suspension Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit

More information

NICHQ Vanderbilt Assessment Scale PARENT Informant

NICHQ Vanderbilt Assessment Scale PARENT Informant D3 NICHQ Vanderbilt Assessment Scale PARENT Informant Today s Date: Child s Name: Date of Birth: Directions: Each rating should be considered in the context of what is appropriate for the age of your child.

More information

STP Alumni Newsletter

STP Alumni Newsletter STP Alumni Newsletter Wave 5 Begins! As many of you know, the summer program follow up study was reviewed very favorably at the National Institutes of Health last year, resulting in our receiving funding

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: Reference Number: CP.PMA_10.11.7 Effective Date: 07.16 Last Review Date: 04.18 Line of Business: Cenpatico Medicaid Arizona Revision Log See Important Reminder at the end of this policy

More information

Arkansas Department of Health

Arkansas Department of Health Arkansas Department of Health 4815 West Markham Street Little Rock, Arkansas 72205-3867 Telephone (501) 661-2000 Governor Mike Beebe Nathaniel Smith, MD, MPH, Interim Director and State Health Officer

More information

ADHD Information and Instructions

ADHD Information and Instructions ADHD Information and Instructions This ADHD information packet will answer many of the questions you may have concerning your child s appointment. Please read everything carefully prior to your visit and

More information

Big Lots Behavioral Health. Prescribing Guidelines for Behavioral Health

Big Lots Behavioral Health. Prescribing Guidelines for Behavioral Health Big Lots Behavioral Health Prescribing Guidelines for Behavioral Health Prescribing for Behavioral Health This document was developed by Nationwide Children s Hospital in conjunction with Partners For

More information

Humberto Nagera M.D. Director, The Carter-Jenkins Center Psychoanalyst, Children, Adolescents and Adults Professor of Psychiatry at USF Professor

Humberto Nagera M.D. Director, The Carter-Jenkins Center Psychoanalyst, Children, Adolescents and Adults Professor of Psychiatry at USF Professor The Carter Jenkins Center presents 1 Humberto Nagera M.D. Director, The Carter-Jenkins Center Psychoanalyst, Children, Adolescents and Adults Professor of Psychiatry at USF Professor Emeritus of Psychiatry

More information

Medication Information for Parents and Teachers

Medication Information for Parents and Teachers Medication Information for Parents and Teachers Modafinil Provigil Armodafinil Nuvigil General Information About Medication Each child and adolescent is different. No one has exactly the same combination

More information

Stimulants. The psychostimulants, or more simply known as stimulants, are used primarily in treating attention-deficit/ Dosing Information

Stimulants. The psychostimulants, or more simply known as stimulants, are used primarily in treating attention-deficit/ Dosing Information Adderall and Adderall-XR (amphetamine mixtures) Concerta (methylphenidate, controlled Dexedrine, Dexedrine Spansules (dextroamphetamine) Focalin (dexmethylphenidate) Metadate, Metadate-ER, and Metadate-CD

More information

Behavioral Health. Behavioral Health. Prescribing Guidelines

Behavioral Health. Behavioral Health. Prescribing Guidelines Behavioral Health Behavioral Health Prescribing Guidelines Attention Deficit/Hyperactivity Disorder (ADHD) Start with a first line medication, either from the methylphenidate or dextroamphetamine-amphetamine

More information

Market Potential for MDX Alcobra Investor Breakfast July 15, 2014

Market Potential for MDX Alcobra Investor Breakfast July 15, 2014 Market Potential for MDX Alcobra Investor Breakfast July 15, 2014 Forward Looking Statement This presentation includes statements that are, or may be deemed, forward-looking statements. In some cases,

More information

Lake Psychological Services, LLC

Lake Psychological Services, LLC Lake Psychological Services, LLC Welcome to Lake Psychological Services and thanks for choosing our office for your health care needs. Seeking treatment is not an easy decision and you may have questions

More information

Date: Child s Name: Date of Birth:

Date: Child s Name: Date of Birth: Date: Child s Name: Date of Birth: Dear Parent: Because ADD/ADHD is a chronic condition requiring ongoing medication, it is our policy to follow your child every 6 months to monitor his or her progress

More information

London Medicines Information Service

London Medicines Information Service London Medicines Information Service Extended-release methylphenidate a review of the pharmacokinetic profiles available March 2018 First authored by Martin Bradley (martin.bradley@gstt.nhs.uk) May 2016

More information

Drug Class Review. Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder

Drug Class Review. Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder Drug Class Review Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder Final Update 5 Report July 2015 The purpose of reports is to make available information regarding the comparative

More information

Attention Deficit Hyperactivity Disorder State of the Art. Christopher Okiishi, MD

Attention Deficit Hyperactivity Disorder State of the Art. Christopher Okiishi, MD Attention Deficit Hyperactivity Disorder State of the Art Christopher Okiishi, MD What is ADHD? Three subtypes: Inattentive (under diagnosed, esp. in girls) Hyperactive Impulsive Combined Impairments must

More information

Big Lots Behavioral Health. Prescribing Guidelines for Behavioral Health

Big Lots Behavioral Health. Prescribing Guidelines for Behavioral Health Big Lots Behavioral Health Prescribing Guidelines for Behavioral Health Prescribing for Behavioral Health This document was developed by Nationwide Children s Hospital in conjunction with Partners For

More information

ADHD: Management Update

ADHD: Management Update 4/5/17 Conflicts of Interest ADHD: Management Update I have no conflicts to disclose. Jennifer R. Walton, MD, MPH, FAAP April 7, 2017 ADHD: DSM-5 Definition Objectives To briefly review ADHD diagnostic

More information

Pharmacy Prior Authorization Clinical Guideline for Attention Deficit Disorder/Attention Deficit Hyperactivity CNS Stimulants

Pharmacy Prior Authorization Clinical Guideline for Attention Deficit Disorder/Attention Deficit Hyperactivity CNS Stimulants AETNA BETTER HEALTH Pharmacy Prior Authorization Clinical Guideline for Attention Deficit Disorder/Attention Deficit Hyperactivity CNS Stimulants Formulary amphetamine/dextroamphetamine IR, ER (generic

More information

2. Receive the Guidelines for the Allergist letter which is to be given to the prescribing allergist physician.

2. Receive the Guidelines for the Allergist letter which is to be given to the prescribing allergist physician. POLICY: Name of Policy Allergy Immunotherapy Section Clinical Records and Health Information Date Effective January 20, 2005 Date Last Reviewed June 21, 2017 Responsible for Review UCF SHS Director Approved

More information

Dextroamphetamine vs ritalin

Dextroamphetamine vs ritalin P ford residence southampton, ny Dextroamphetamine vs ritalin Photo by istock.com/ognianm What are prescription stimulants? 24-12-2016 Find a comprehensive guide to possible side effects including common

More information

Cerebral Stimulant and ADHD Drugs Prior Authorization Request

Cerebral Stimulant and ADHD Drugs Prior Authorization Request Commonwealth of Massachusetts MassHealth Drug Utilization Review Program P.O. Box 2586, Worcester, MA 01613-2586 Fax: 1-877-208-7428 Phone: 1-800-745-7318 Cerebral Stimulant and ADHD Drugs Prior Authorization

More information

35 mg NF -- Dextroamphetamine Sulfate IR Tablets: Zenzedi IR Ttablets: Dextroamphetamine Sulfate ER Capsules: 15 mg ProCentra Solution.

35 mg NF -- Dextroamphetamine Sulfate IR Tablets: Zenzedi IR Ttablets: Dextroamphetamine Sulfate ER Capsules: 15 mg ProCentra Solution. MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: ADHD Medications P&T DATE 12/13/2017 CLASS: Psychiatric Disorders REVIEW HISTORY 12/16, 9/15, 5/12, 5/10, LOB: MCL (MONTH/YEAR)

More information

How long does it take strattera to take effect

How long does it take strattera to take effect How long does it take strattera to take effect The Borg System is 100 % How long does it take strattera to take effect How long does it take for strattera to work? Asked 24 Apr 2013 by Anonymous Updated

More information

Adderall therapeutic range

Adderall therapeutic range Adderall therapeutic range Find patient medical information for Adderall Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Levels of amphetamine

More information

3/24/14. Top 3 ADHD Medication Pitfalls: How to Know if Your ADHD Medication is Working for You

3/24/14. Top 3 ADHD Medication Pitfalls: How to Know if Your ADHD Medication is Working for You Minimize the Madness- Taking the Mystery Out of ADHD Medications Class 4 Top 3 ADHD Medication Pitfalls: How to Know if Your ADHD Medication is Working for You Presented by Laurie Dupar, Certified ADHD

More information

Treating Disruptive Behavior Disorders in Children and Teens. A Review of the Research for Parents and Caregivers

Treating Disruptive Behavior Disorders in Children and Teens. A Review of the Research for Parents and Caregivers Treating Disruptive Behavior Disorders in Children and Teens A Review of the Research for Parents and Caregivers e Is This Information Right for Me? This information is for you if: A health care professional*

More information

PALS NEWSLETTER. February A newsletter of the Pittsburgh ADHD Longitudinal Study STUDY UPDATE PARKING IN OAKLAND

PALS NEWSLETTER. February A newsletter of the Pittsburgh ADHD Longitudinal Study STUDY UPDATE PARKING IN OAKLAND PALS NEWSLETTER A newsletter of the Pittsburgh ADHD Longitudinal Study STUDY UPDATE As you may remember, we formally changed the way that we refer to the study to the PALS Study for the Pittsburgh ADHD

More information

This study helped researchers learn if a medicine called SHP465 could help adults with ADHD have fewer symptoms and/or less severe symptoms.

This study helped researchers learn if a medicine called SHP465 could help adults with ADHD have fewer symptoms and/or less severe symptoms. Summary of Clinical Trial Results Thank you! Thank you to those people who took part in this clinical study. This study helped researchers learn if a medicine called SHP465 could help adults with ADHD

More information

SHARED CARE GUIDELINE

SHARED CARE GUIDELINE SHARED CARE GUIDELINE Methylphenidate in the treatment of Attention Deficit Hyperactivity Disorder in Children, Young People and Adults Implementation Date: June 2015 Review Date: June 2017 This guidance

More information

ADHD Medications Table

ADHD Medications Table Stimulants are the first line treatment of choice for ADHD followed by Non-Stimulants, then off-label medications. We are providing this list of medications so that you can be familiar with the common

More information

Attention Deficit Hyperactivity Disorder (ADHD) BY MARK FABER M.D.

Attention Deficit Hyperactivity Disorder (ADHD) BY MARK FABER M.D. Attention Deficit Hyperactivity Disorder (ADHD) BY MARK FABER M.D. PREVALENCE & STATISTICS 6-8% of all children have ADHD (CDC Statistical Data) Age of onset: 7 years old (Prior DSM-IV) 12 years old (Current

More information

ADD/ADHD Patient Intake Form. Patients age 18 years or older

ADD/ADHD Patient Intake Form. Patients age 18 years or older Lisa Sachdev, D.O. ADD/ADHD Patient Intake Form Patients age 18 years or older Please fill out the following questionnaire prior to your first appointment. You must be completely honest and detailed in

More information

Trouble shooting medication adjustment and side effect management in children with ADHD

Trouble shooting medication adjustment and side effect management in children with ADHD Trouble shooting medication adjustment and side effect management in children with ADHD Drs. Joanna Holland and Sarah Manos 44 th Annual Dalhousie Spring Refresher April 5, 2018 Disclosure We have no disclosures

More information

DSM-5 Criteria for ADHD from

DSM-5 Criteria for ADHD from DSM-5 Criteria for ADHD from http://www.cdc.gov/ncbddd/adhd/diagnosis.html People with ADHD show a persistent pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or

More information

Conversion from focalin xr to vyvanse

Conversion from focalin xr to vyvanse Conversion from focalin xr to vyvanse The Borg System is 100 % Conversion from focalin xr to vyvanse Sep 3, 2007. The importance of the 'conversion' dosing listed above relates to those people who may

More information

Policy and Issuance Patient Age Group: ( ) N/A ( ) All Ages ( ) Newborns ( X) Pediatric ( X) Adult

Policy and Issuance Patient Age Group: ( ) N/A ( ) All Ages ( ) Newborns ( X) Pediatric ( X) Adult Applies To: Ambulatory Services Responsible Department: Ambulatory Admin Revised: 02/2018 Title: Controlled Substance Prescription Processing, Security Policy and Issuance Patient Age Group: ( ) N/A (

More information

Conversion table methylphenidate to vyvanse

Conversion table methylphenidate to vyvanse P ford residence southampton, ny Conversion table methylphenidate to vyvanse Lisdexamfetamine dimesylate is converted to dextoamphetamine and L- lysine, which is of ADDERALL XR (10, 20, or 30 mg), Vyvanse

More information

Attention Deficit Hyperactivity Disorder: Module 3

Attention Deficit Hyperactivity Disorder: Module 3 Attention Deficit Hyperactivity Disorder: Module 3 The information in this training module was taken from an online article by the National Institute of Mental Health. (http://www.nimh.nih. gov/health/publications/adhd/complete-publication.shtml)

More information

Attention Deficit Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder Page 1 of 5 Attention Deficit Hyperactivity Disorder ADHD is a common condition that mainly affects behaviour. Children with this condition show persistent restlessness, impulsiveness and/or inattention.

More information

Can you get adderall in italy

Can you get adderall in italy Can you get adderall in italy Search 21-5-2017 What is the easiest way to get medicine online?. If you have ADD, the easiest way to get Adderall is to just talk to a. Can you buy Adderall in Italy?. It

More information

AP PSYCHOLOGY SYLLABUS Mrs. Dill, La Jolla High School

AP PSYCHOLOGY SYLLABUS Mrs. Dill, La Jolla High School AP PSYCHOLOGY SYLLABUS 2018-2019 Mrs. Dill, La Jolla High School PURPOSE OF THE COURSE: The purpose of the Advanced Placement course in Psychology is to introduce students to the systematic and scientific

More information

Ritalin mg equal to adderall

Ritalin mg equal to adderall P ford residence southampton, ny Ritalin mg equal to adderall Snorting Ritalin will make you go through a pill every ten mi a, then 2 every 10. Try or Ritalin it got me good for three hours and wasn't

More information

Ask The Shrink: ADHD

Ask The Shrink: ADHD Ask The Shrink: ADHD Theodore A. Petti, MD Professor of Psychiatry Division of Child and Adolescent Psychiatry Robert Wood Johnson Medical School PPC Hub Psychiatrist Hackensack Meridian Hubs @ Saint Peter'

More information

C a n y o u c r u s h r i t a l i n t a b l e t

C a n y o u c r u s h r i t a l i n t a b l e t C a n y o u c r u s h r i t a l i n t a b l e t Caffeine for ADHD. Does It REALLY Work and should I give it to my TEENs? Pharmacists reveal the truth and recommended dose to start. A recent article in

More information

Management of Pediatric Attention Deficit & Hyperactivity Disorder (ADHD) Clinical Practice Guideline MedStar Health

Management of Pediatric Attention Deficit & Hyperactivity Disorder (ADHD) Clinical Practice Guideline MedStar Health Management of Pediatric Attention Deficit & Hyperactivity Disorder (ADHD) Clinical Practice Guideline MedStar Health These guideli es are pro ided to assist physi ia s a d other clinicians in making decisions

More information

Options for Medication Management: Rx and OTC/Natural Treatments AMY NEWMEYER MD CHKD DIVISION OF DEVELOPMENTAL PEDIATRICS MARCH 24, 2018.

Options for Medication Management: Rx and OTC/Natural Treatments AMY NEWMEYER MD CHKD DIVISION OF DEVELOPMENTAL PEDIATRICS MARCH 24, 2018. Options for Medication Management: Rx and OTC/Natural Treatments AMY NEWMEYER MD CHKD DIVISION OF DEVELOPMENTAL PEDIATRICS MARCH 24, 2018 Disclosures I have no conflicts of interest to disclose 1 Objectives

More information

What are the most common signs of ADHD? And what are the most common medication interventions?

What are the most common signs of ADHD? And what are the most common medication interventions? What are the most common signs of ADHD? And what are the most common medication interventions? Bennett Gertz, MD, FAAP Developmental Behavioral Pediatrician Children s Developmental Health Services Albertina

More information

Management Guidance HR72 On-Call Policy. The Trust s Approach to Compensatory Rest

Management Guidance HR72 On-Call Policy. The Trust s Approach to Compensatory Rest Management Guidance HR72 On-Call Policy The Trust s Approach to Compensatory Rest General Principles Compensatory rest may be granted if either: An individual s daily or weekly rest requirements (as stated

More information

Adderall booster dose with 60 mg vyvanse

Adderall booster dose with 60 mg vyvanse Adderall booster dose with 60 mg vyvanse The Borg System is 100 % Adderall booster dose with 60 mg vyvanse I've been on Vyvanse for 3 weeks now and love it. However, my doctor has to continue to increase

More information

A REVIEW OF STIMULANTS FOR ADHD FOR THE PRIMARY CARE PROVIDER JAMES C. ASHWORTH MD MEDICAL DIRECTOR UNIVERSITY OF UTAH NEUROPSYCHIATRIC INSTITUTE

A REVIEW OF STIMULANTS FOR ADHD FOR THE PRIMARY CARE PROVIDER JAMES C. ASHWORTH MD MEDICAL DIRECTOR UNIVERSITY OF UTAH NEUROPSYCHIATRIC INSTITUTE A REVIEW OF STIMULANTS FOR ADHD FOR THE PRIMARY CARE PROVIDER JAMES C. ASHWORTH MD MEDICAL DIRECTOR UNIVERSITY OF UTAH NEUROPSYCHIATRIC INSTITUTE OVERVIEW Review Stimulant Treatment for ADHD STIMULANTS

More information

ADHD Stimulant Step Therapy Program

ADHD Stimulant Step Therapy Program ADHD Stimulant Step Therapy Program Policy Number: 5.01.592 Last Review: 7/2018 Origination: 7/2017 Next Review: 7/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage

More information

Psychiatric Medications. Positive and negative effects in the classroom

Psychiatric Medications. Positive and negative effects in the classroom Psychiatric Medications Positive and negative effects in the classroom Teaching the Medicated Child Beverly Bryant, M.D. Hattiesburg Clinic 9/17/14 Introduction According to the National Survey of Children

More information

Pharmacy Medical Necessity Guidelines: ADHD CNS Stimulant Medications

Pharmacy Medical Necessity Guidelines: ADHD CNS Stimulant Medications Pharmacy Medical Necessity Guidelines: ADHD CNS Stimulant Medications Effective: January 1, 2018 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy

More information

29 th Annual Learning Symposium

29 th Annual Learning Symposium Friday, January 5, 9 Breakout Session 9 th Annual Learning Symposium ADHD & Medication Steven Pliszka, M.D. Dr. Steven Pliszka is a Dielmann Distinguished Professor and Chair of the Department of Psychiatry

More information

STRATTERA Generic name: atomoxetine hydrochloride

STRATTERA Generic name: atomoxetine hydrochloride 1 Medication Guide PV 5850 AMP STRATTERA Generic name: atomoxetine hydrochloride Read this information carefully before you start taking STRATTERA (Stra-TAIR-a) to learn about the benefits and risks of

More information

Facts about ADHD drugs as treatment

Facts about ADHD drugs as treatment Facts about ADHD drugs as treatment Common ADHD drugs as treatment Medication Stimulants Methylphenidate Dexmethylphenidate Amphetamine Non-Stimulants Straterra Guanfacine ER (Intuniv) Clonidine (Kapvay)

More information

Pharmacy Medical Necessity Guidelines: CNS Stimulant Medications

Pharmacy Medical Necessity Guidelines: CNS Stimulant Medications Pharmacy Medical Necessity Guidelines: CNS Stimulant Medications Effective: June 1, 2017 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy

More information

10 mg adderall equals how much caffeine

10 mg adderall equals how much caffeine P ford residence southampton, ny 10 mg adderall equals how much caffeine Dramamine Used to reduce motion sickness. Canine Dose: 12.5 50mg every 8 hours. Feline Dose: 12.5 mg every 8 hours. I have taken

More information

A Physician's Perspective

A Physician's Perspective A Physician's Perspective by Theodore Mandelkorn, MD Part one Introduction Who should take medications, and why? What improvement should be seen? Who should prescribe medications? Medical trials What is

More information

ADHD Explanation 5: Medications used in ADHD

ADHD Explanation 5: Medications used in ADHD ADHD Explanation 5: Medications The aim of treatment is efficient functioning and achieving goals in life It is most important to find the dose of medications that works best As children grow they may

More information

SHARED PRESCRIBING GUIDELINE

SHARED PRESCRIBING GUIDELINE working in partnership with Kingston Richmond Wandsworth SHARED PRESCRIBING GUIDELINE Sutton & Merton Methylphenidate, Dexamfetamine and Atomoxetine for Attention Deficit Hyperactivity Disorder in patients

More information

ADD/ADHD Assessment. for patients age 18 years or older. Name: Date of Birth: Age: Sex: Today s Date:

ADD/ADHD Assessment. for patients age 18 years or older. Name: Date of Birth: Age: Sex: Today s Date: Lisa Sachdev, D.O. ADD/ADHD Assessment for patients age 18 years or older In order for us to be able to fully evaluate you, please fill out the following questionnaire to the best of your ability. We realize

More information

Central Nervous System Stimulants Drug Class Prior Authorization Protocol

Central Nervous System Stimulants Drug Class Prior Authorization Protocol Line of Business: Medi-Cal Effective Date: August 16, 2017 Revision Date: August 16, 2017 Central Nervous System Stimulants Drug Class Prior Authorization Protocol This policy has been developed through

More information

Methylphenidate Shared Care Agreement For attention deficit hyperactivity disorder (ADHD) in adults Effective Shared Care Agreement

Methylphenidate Shared Care Agreement For attention deficit hyperactivity disorder (ADHD) in adults Effective Shared Care Agreement Methylphenidate Shared Care Agreement For attention deficit hyperactivity disorder (ADHD) in adults Effective Shared Care Agreement Section 1: Shared Care arrangements and responsibilities Section 1.1

More information

Could I Have Attention-Deficit/ Hyperactivity Disorder (ADHD)?

Could I Have Attention-Deficit/ Hyperactivity Disorder (ADHD)? Could I Have Attention-Deficit/ Hyperactivity Disorder (ADHD)? Finding an Answer to ADHD as an Adult Do you feel that you have struggled throughout your life with poor concentration, inattention, impulsivity,

More information

Recognition and Treatment of ADHD in Primary Care Settings. Disclosure 11/6/2013. Objectives

Recognition and Treatment of ADHD in Primary Care Settings. Disclosure 11/6/2013. Objectives Southern California Permanente Medical Group Pediatric Symposium Hyatt, Long Beach CA. 11/1/13 Recognition and Treatment of ADHD in Primary Care Settings Martin T. Stein, M.D. Professor of Pediatrics Division

More information

Understanding the Challenges of Managing Mental Health in the Workplace With a Focus on ADHD

Understanding the Challenges of Managing Mental Health in the Workplace With a Focus on ADHD Understanding the Challenges of Managing Mental Health in the Workplace With a Focus on ADHD Dr. Don Duncan Clinical Director BC Interior ADHD Clinic Kelowna, BC Mental Health Summit Vancouver, BC December

More information

Attention Deficit Hyperactivity Disorder in Children and Adults

Attention Deficit Hyperactivity Disorder in Children and Adults Attention Deficit Hyperactivity Disorder in Children and Adults Steven R. Pliszka, MD Professor and Chair Department of Psychiatry The University of Texas Health Science Center at San Antonio Speaker Disclosure

More information

Updated: 08/2017 DMMA Approved: 11/2017

Updated: 08/2017 DMMA Approved: 11/2017 Request for Prior Authorization for Therapy to Treat Binge Eating Disorder Website Form www.highmarkhealthoptions.com Submit request via: Fax - 1-855-476-4158 All requests for medications to treat Binge

More information

How to take your Opioid Pain Medication

How to take your Opioid Pain Medication How to take your Opioid Pain Medication Today your doctor gave you a prescription for medication to help relieve your pain. The pain medication is called an opioid or narcotic. Taking pain medication,

More information

Clinical Policy: CNS Stimulants Reference Number: CP.PMN.XX Effective Date: Last Review Date: Line of Business: Commercial, Medicaid

Clinical Policy: CNS Stimulants Reference Number: CP.PMN.XX Effective Date: Last Review Date: Line of Business: Commercial, Medicaid Clinical Policy: Reference Number: CP.PMN.XX Effective Date: 03.01.18 Last Review Date: 02.18 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of this policy for important

More information

Psychotropic Medication

Psychotropic Medication FOM 802-1 1 of 10 OVERVIEW The use of psychotropic medication as part of a child s comprehensive mental health treatment plan may be beneficial and should include consideration of all alternative interventions.

More information

DEAF CHILDREN WITH ADHD AND LEARNING DIFFICULTIES

DEAF CHILDREN WITH ADHD AND LEARNING DIFFICULTIES DEAF CHILDREN WITH ADHD AND LEARNING DIFFICULTIES Scott R. Smith, MD, MPH Developmental-Behavioral Pediatrician University of Rochester Medical Center Common Complaints about Children with Problems Your

More information

Fall 2018: Spring 2019:

Fall 2018: Spring 2019: Fall 2018: Fall 2018 Opening Weekend Fall Break 2018 Thanksgiving Break 2018 Finals Week Fall 2018 Winter Break 2018 Spring 2019: Spring 2019 Opening Weekend Spring Break 2019 Easter Break 2019 Finals

More information

Guidelines for the Utilization of Psychotropic Medications for Children in Foster Care. Illinois Department of Children and Family Services

Guidelines for the Utilization of Psychotropic Medications for Children in Foster Care. Illinois Department of Children and Family Services Guidelines for the Utilization of Psychotropic Medications for Children in Foster Care Illinois Department of Children and Family Services Introduction With few exceptions, children and adolescents in

More information

H NDS-ONHealth. Prescription Drug Abuse. Drug overdose death rates in the United States have more than tripled since 1990 and have never been higher.

H NDS-ONHealth. Prescription Drug Abuse. Drug overdose death rates in the United States have more than tripled since 1990 and have never been higher. H NDS-ONHealth Health Wave Newsletter, October 2013 Visit us on our website at www.healthwaveinc.com Drug overdose death rates in the United States have more than tripled since 1990 and have never been

More information

Update on the Treatment of ADHD 2019

Update on the Treatment of ADHD 2019 Update on the Treatment of ADHD 2019 James H. Beard, Jr., M.D, FAAP Developmental-Behavioral Pediatrician Division of Developmental Pediatrics The Rights of ADHD The right diagnosis of ADHD and co morbidities

More information

Department of Health and Human Services Food and Drug Administration 5600 Fishers Lane (HFI-40) Rockville, MD February 2000 (FDA)

Department of Health and Human Services Food and Drug Administration 5600 Fishers Lane (HFI-40) Rockville, MD February 2000 (FDA) Department of Health and Human Services Food and Drug Administration 5600 Fishers Lane (HFI-40) Rockville, MD 20857 February 2000 (FDA) 00-3237 Be More Careful With Medicines The Food and Drug Administration,

More information

Clinical Policy: CNS Stimulants Reference Number: CP.PMN.92 Effective Date: Last Review Date: Line of Business: Commercial, Medicaid

Clinical Policy: CNS Stimulants Reference Number: CP.PMN.92 Effective Date: Last Review Date: Line of Business: Commercial, Medicaid Clinical Policy: Reference Number: CP.PMN.92 Effective Date: 03.01.18 Last Review Date: 02.18 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of this policy for important

More information

Extended release adderall

Extended release adderall Extended release adderall The Borg System is 100 % Extended release adderall Use Adderall XR (dextroamphetamine and amphetamine extended-release capsules (adderall XR)) as you were told by your doctor.

More information

For Students Who are Deaf or Hard of Hearing

For Students Who are Deaf or Hard of Hearing For Students Who are Deaf or Hard of Hearing June 3 - June 15, 2018 Driver Education for Students Who are Deaf or Hard of Hearing Two-week Long Summer School for Eligible Ohio Teens Columbus, OH The Ohio

More information

Clinical Policy: Atomoxetine (Strattera) Reference Number: CP.PST.17 Effective Date:

Clinical Policy: Atomoxetine (Strattera) Reference Number: CP.PST.17 Effective Date: Clinical Policy: (Strattera) Reference Number: CP.PST.17 Effective Date: 08.01.17 Last Review Date: 08.18 Line of Business: Medicaid Revision Log See Important Reminder at the end of this policy for important

More information

Adolescent Sleep Disorder Questionnaire For Children Ages PATIENT NAME: (Please print clearly) Patient s Date of Birth: Age: Male Female

Adolescent Sleep Disorder Questionnaire For Children Ages PATIENT NAME: (Please print clearly) Patient s Date of Birth: Age: Male Female (PATIENT) Adolescent Sleep Disorder Questionnaire For Children Ages 12-17 Instructions: Please review this form for accuracy prior to submission. You may complete this information prior to arrival at the

More information